Home » Topics » BioWorld Science

BioWorld Science
RSS

COX-2 inhibitors under study at Abbott

Jan. 8, 1998

Protein farnesyltransferase inhibitors disclosed by Schering-Plough

Jan. 8, 1998

Photofrin approval sought in nine additional European countries

Jan. 7, 1998

NDA filed for betamethasone mousse

Jan. 7, 1998

U.S. Bioscience signs CRADA for novel AIDS drug

Jan. 7, 1998

FR-167653 protects against ischemia-reperfusion injury in lung in canine model

Jan. 7, 1998

Effects of TxA2 antagonists on IL-8-induced bronchial hyperresponsiveness

Jan. 7, 1998

ABX-CBL evaluated in phase II GVHD trial

Jan. 7, 1998

Astra to launch new tablet formulation of Losec in Sweden

Jan. 7, 1998

Theratechnologies to begin clinical testing of leukemia Rx

Jan. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...